Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
How to: prophylactic interventions for prevention of Clostridioides difficile infectionElena Reigadas, Joffrey van Prehn, Marco Falcone, et al.
Der Urologe. Ausg. A|August 23, 2021
[Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]T Schiereck, S Yeldan, J Kranz, et al.
Annals of Hematology|May 4, 2021
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysisSarah Weber, Aaron Magh, Michael Hogardt, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 13, 2018
Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)Maria J G T Vehreschild, Surabhi Taori, Simon D Goldenberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 1, 2019
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysisP Koehler, M Stecher, O A Cornely, et al.
Viruses|September 28, 2021
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484QAlexander Wilhelm, Tuna Toptan, Christiane Pallas, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 9, 2018
Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)Maria J G T Vehreschild, Surabhi Taori, Simon D Goldenberg, et al.
Epidemiology and Infection|December 14, 2011
Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patientsJ J Vehreschild, P J Bröckelmann, C Bangard, et al.
Infection|March 6, 2026
Visceral leishmaniasis clinically disguised as Kaposi's sarcoma: a diagnostic challenge in people living with HIVLene T Tscharntke, Theresa Alisch, Gerrit Burger, et al.
Infection|March 27, 2020
Clostridioides difficile infections in the intensive care unit: a monocentric cohort studyRebeca Cruz Aguilar, Jon Salmanton-García, Jonathan Carney, et al.
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
How to: prophylactic interventions for prevention of Clostridioides difficile infectionElena Reigadas, Joffrey van Prehn, Marco Falcone, et al.
Der Urologe. Ausg. A|August 23, 2021
[Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]T Schiereck, S Yeldan, J Kranz, et al.
Annals of Hematology|May 4, 2021
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysisSarah Weber, Aaron Magh, Michael Hogardt, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 13, 2018
Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)Maria J G T Vehreschild, Surabhi Taori, Simon D Goldenberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 1, 2019
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysisP Koehler, M Stecher, O A Cornely, et al.
Viruses|September 28, 2021
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484QAlexander Wilhelm, Tuna Toptan, Christiane Pallas, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 9, 2018
Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)Maria J G T Vehreschild, Surabhi Taori, Simon D Goldenberg, et al.
Epidemiology and Infection|December 14, 2011
Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patientsJ J Vehreschild, P J Bröckelmann, C Bangard, et al.
Infection|March 6, 2026
Visceral leishmaniasis clinically disguised as Kaposi's sarcoma: a diagnostic challenge in people living with HIVLene T Tscharntke, Theresa Alisch, Gerrit Burger, et al.
Infection|March 27, 2020
Clostridioides difficile infections in the intensive care unit: a monocentric cohort studyRebeca Cruz Aguilar, Jon Salmanton-García, Jonathan Carney, et al.
Pageof 23